| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.593 | 0.012 | 0.593 | 5 Hydroxytryptamine release inhibitor | 0.482 0.039 DBMET00415 | ||
| 0.548 | 0.004 | 0.548 | Protein kinase (CK1) inhibitor | 0.352 0.012 DBMET00415 | ||
| 0.528 | 0.013 | 0.528 | MAP kinase kinase 6 inhibitor | 0.44 0.038 DBMET00415 | ||
| 0.53 | 0.016 | 0.53 | Nootropic | 0.474 0.024 DBMET00415 | ||
| 0.529 | 0.019 | 0.529 | GABA C receptor rho-3 antagonist | 0.513 0.022 DBMET00415 | ||
| 0.502 | 0.028 | 0.502 | Histamine release inhibitor | 0.306 0.121 DBMET00415 | ||
| 0.502 | 0.033 | 0.502 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.464 0.052 DBMET00415 | ||
| 0.459 | 0.004 | 0.459 | GABA C receptor agonist | 0.313 0.009 DBMET00415 | ||
| 0.448 | 0.002 | 0.448 | MAP kinase kinase 3 inhibitor | 0.385 0.003 DBMET00415 | ||
| 0.448 | 0.004 | 0.448 | Histone deacetylase stimulant | 0.132 0.013 DBMET00415 | ||
| 0.448 | 0.004 | 0.448 | Histone deacetylase SIRT1 stimulant | 0.132 0.013 DBMET00415 | ||
| 0.445 | 0.004 | 0.445 | Glutamate (mGluR) agonist | 0.215 0.008 DBMET00415 | ||
| 0.404 | 0.004 | 0.404 | Glutamate (mGluR) antagonist | 0.209 0.009 DBMET00415 | ||
| 0.397 | 0.003 | 0.397 | Glutamate (mGluR group II) agonist | 0.148 0.005 DBMET00415 | ||
| 0.391 | 0.003 | 0.391 | Glutamate (mGluR2) agonist | 0.141 0.005 DBMET00415 | ||
| 0.367 | 0.006 | 0.367 | Glutamate receptor antagonist | 0.224 0.02 DBMET00415 | ||
| 0.373 | 0.025 | 0.373 | Peroxidase inhibitor | 0.311 0.035 DBMET00415 | ||
| 0.36 | 0.015 | 0.36 | TRKC antagonist | 0.156 0.096 DBMET00415 | ||
| 0.348 | 0.005 | 0.379 | Polo-like kinase-3 inhibitor | 0.379 0.004 DBMET00415 | DBMET00415 | |
| 0.344 | 0.004 | 0.344 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.228 0.006 DBMET00415 | ||
| 0.366 | 0.033 | 0.366 | Superoxide dismutase inhibitor | 0.258 0.069 DBMET00415 | ||
| 0.355 | 0.024 | 0.355 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.295 0.041 DBMET00415 | ||
| 0.316 | 0.006 | 0.316 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.214 0.012 DBMET00415 | ||
| 0.314 | 0.006 | 0.314 | Histidine decarboxylase inhibitor | 0.206 0.012 DBMET00415 | ||
| 0.317 | 0.014 | 0.317 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.338 | 0.039 | 0.338 | Insulysin inhibitor | 0.312 0.052 DBMET00415 | ||
| 0.303 | 0.005 | 0.303 | Porphobilinogen synthase inhibitor | 0.177 0.015 DBMET00415 | ||
| 0.325 | 0.027 | 0.325 | RNA-directed DNA polymerase inhibitor | 0.276 0.038 DBMET00415 | ||
| 0.316 | 0.021 | 0.316 | Protein kinase C nu inhibitor | 0.12 0.093 DBMET00415 | ||
| 0.294 | 0.004 | 0.388 | Nav1.8 sodium channel blocker | 0.388 0.004 DBMET00415 | DBMET00415 | |
| 0.312 | 0.024 | 0.312 | MAP-kinase-activated kinase 5 inhibitor | 0.286 0.038 DBMET00415 | ||
| 0.29 | 0.014 | 0.29 | Nitric-oxide synthase stimulant | 0.258 0.027 DBMET00415 | ||
| 0.281 | 0.007 | 0.281 | Check point kinase 2 inhibitor | 0.206 0.015 DBMET00415 | ||
| 0.27 | 0.006 | 0.27 | Protein kinase C mu inhibitor | 0.201 0.012 DBMET00415 | ||
| 0.302 | 0.04 | 0.302 | Anticonvulsant | 0.177 0.102 DBMET00415 | ||
| 0.267 | 0.006 | 0.267 | Glutamate receptor agonist | 0.097 0.039 DBMET00415 | ||
| 0.301 | 0.043 | 0.301 | DNA synthesis inhibitor | 0.267 0.057 DBMET00415 | ||
| 0.286 | 0.031 | 0.286 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.163 0.107 DBMET00415 | ||
| 0.324 | 0.07 | 0.324 | Calcium channel activator | 0.252 0.145 DBMET00415 | ||
| 0.31 | 0.057 | 0.31 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.245 0.111 DBMET00415 | ||
| 0.254 | 0.009 | 0.254 | Histone deacetylase class III inhibitor | 0.141 0.051 DBMET00415 | ||
| 0.267 | 0.025 | 0.267 | Protein kinase (CK1) gamma inhibitor | |||
| 0.258 | 0.024 | 0.258 | Heat shock protein 90 alpha antagonist | 0.138 0.1 DBMET00415 | ||
| 0.244 | 0.014 | 0.247 | Ferrochelatase inhibitor | 0.247 0.014 DBMET00415 | DBMET00415 | |
| 0.245 | 0.021 | 0.245 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.241 | 0.02 | 0.332 | Sodium channel blocker | 0.332 0.008 DBMET00415 | DBMET00415 | |
| 0.222 | 0.009 | 0.253 | GABA C receptor antagonist | 0.253 0.006 DBMET00415 | DBMET00415 | |
| 0.218 | 0.006 | 0.249 | GABA C receptor rho-1 antagonist | 0.249 0.004 DBMET00415 | DBMET00415 | |
| 0.215 | 0.005 | 0.215 | Histone deacetylase SIRT2 inhibitor | 0.104 0.026 DBMET00415 | ||
| 0.248 | 0.039 | 0.248 | LIM domain kinase 1 inhibitor | 0.168 0.082 DBMET00415 | ||
| 0.261 | 0.054 | 0.261 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.179 0.089 DBMET00415 | ||
| 0.276 | 0.069 | 0.289 | Aryl hydrocarbon receptor agonist | 0.289 0.064 DBMET00415 | DBMET00415 | |
| 0.299 | 0.093 | 0.299 | Angiogenesis inhibitor | |||
| 0.227 | 0.022 | 0.227 | Cyclin-dependent kinase 8 inhibitor | 0.15 0.079 DBMET00415 | ||
| 0.217 | 0.012 | 0.217 | Beta amyloid protein antagonist | 0.159 0.035 DBMET00415 | ||
| 0.256 | 0.051 | 0.288 | MAP kinase kinase 2 inhibitor | 0.288 0.039 DBMET00415 | DBMET00415 | |
| 0.21 | 0.006 | 0.21 | Alcohol oxidase inhibitor | 0.093 0.02 DBMET00415 | ||
| 0.226 | 0.023 | 0.226 | Histone deacetylase SIRT1 inhibitor | 0.142 0.068 DBMET00415 | ||
| 0.229 | 0.026 | 0.229 | Nav1.2 sodium channel blocker | |||
| 0.223 | 0.022 | 0.231 | Sodium channel (voltage-gated) blocker | 0.231 0.02 DBMET00415 | DBMET00415 | |
| 0.233 | 0.033 | 0.233 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.266 | 0.066 | 0.266 | 5 Hydroxytryptamine uptake stimulant | 0.225 0.11 DBMET00415 | ||
| 0.24 | 0.044 | 0.24 | Neurotrophic factor enhancer | 0.165 0.117 DBMET00415 | ||
| 0.211 | 0.016 | 0.211 | CF transmembrane conductance regulator agonist | 0.17 0.047 DBMET00415 | ||
| 0.256 | 0.063 | 0.256 | Tyrosine 3 hydroxylase inhibitor | 0.228 0.093 DBMET00415 | ||
| 0.221 | 0.029 | 0.221 | Heat shock protein 90 antagonist | 0.137 0.089 DBMET00415 | ||
| 0.205 | 0.016 | 0.205 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.187 0.027 DBMET00415 | ||
| 0.218 | 0.029 | 0.218 | Alpha-N-acetylglucosaminidase inhibitor | 0.152 0.054 DBMET00415 | ||
| 0.21 | 0.024 | 0.21 | GABA C receptor rho-2 antagonist | 0.209 0.024 DBMET00415 | ||
| 0.22 | 0.036 | 0.22 | 5 Hydroxytryptamine 3E antagonist | 0.203 0.057 DBMET00415 | ||
| 0.192 | 0.01 | 0.192 | Check point kinase 1 inhibitor | 0.136 0.017 DBMET00415 | ||
| 0.233 | 0.054 | 0.233 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.186 | 0.009 | 0.186 | I kappa B kinase inhibitor | 0.112 0.031 DBMET00415 | ||
| 0.18 | 0.005 | 0.18 | Lanosterol 14 alpha demethylase inhibitor | 0.088 0.075 DBMET00415 | ||
| 0.18 | 0.006 | 0.18 | I kappa B kinase 1 inhibitor | |||
| 0.21 | 0.037 | 0.21 | NOS3 expression enhancer | |||
| 0.241 | 0.07 | 0.241 | HERG channel blocker | |||
| 0.224 | 0.054 | 0.224 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.216 0.057 DBMET00415 | ||
| 0.18 | 0.012 | 0.18 | Glutamate dehydrogenase inhibitor | 0.175 0.012 DBMET00415 | ||
| 0.257 | 0.09 | 0.257 | Ca(v)3.3 blocker | |||
| 0.218 | 0.057 | 0.218 | I kappa B kinase epsilon inhibitor | 0.217 0.058 DBMET00415 | ||
| 0.173 | 0.012 | 0.173 | Pim-3 kinase inhibitor | 0.122 0.03 DBMET00415 | ||
| 0.192 | 0.033 | 0.192 | Cell wall synthesis inhibitor | 0.138 0.077 DBMET00415 | ||
| 0.191 | 0.033 | 0.22 | TRKA antagonist | 0.22 0.025 DBMET00415 | DBMET00415 | |
| 0.177 | 0.019 | 0.177 | Pim-1 kinase inhibitor | 0.14 0.031 DBMET00415 | ||
| 0.172 | 0.016 | 0.172 | Alcohol dehydrogenase inhibitor | 0.083 0.075 DBMET00415 | ||
| 0.174 | 0.019 | 0.174 | Adenylate kinase inhibitor | 0.124 0.04 DBMET00415 | ||
| 0.168 | 0.014 | 0.168 | DOPA decarboxylase inhibitor | 0.121 0.044 DBMET00415 | ||
| 0.164 | 0.012 | 0.164 | MAP kinase kinase 1 inhibitor | 0.142 0.02 DBMET00415 | ||
| 0.222 | 0.07 | 0.222 | Pyruvate kinase inhibitor | |||
| 0.185 | 0.034 | 0.185 | Protein kinase (CK1) delta inhibitor | |||
| 0.219 | 0.068 | 0.219 | Clk dual-specificity kinase inhibitor | 0.215 0.071 DBMET00415 | ||
| 0.21 | 0.061 | 0.21 | CDC-like kinase 2 inhibitor | |||
| 0.197 | 0.051 | 0.197 | Succinate dehydrogenase inhibitor | 0.165 0.087 DBMET00415 | ||
| 0.226 | 0.079 | 0.226 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.181 | 0.036 | 0.181 | MAP kinase kinase inhibitor | 0.139 0.058 DBMET00415 | ||
| 0.208 | 0.064 | 0.22 | CDC-like kinase 4 inhibitor | 0.22 0.058 DBMET00415 | DBMET00415 | |
| 0.147 | 0.005 | 0.147 | Polo-like kinase-2 inhibitor | 0.103 0.023 DBMET00415 | ||
| 0.147 | 0.004 | 0.147 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.11 0.005 DBMET00415 | ||
| 0.157 | 0.014 | 0.157 | Polo-like kinase-1 inhibitor | 0.115 0.033 DBMET00415 | ||
| 0.151 | 0.009 | 0.151 | Biliverdin reductase inhibitor | 0.138 0.011 DBMET00415 | ||
| 0.187 | 0.046 | 0.201 | Tyrosine-protein kinase receptor antagonist | 0.201 0.04 DBMET00415 | DBMET00415 | |
| 0.195 | 0.055 | 0.195 | Anticoagulant | 0.131 0.099 DBMET00415 | ||
| 0.159 | 0.021 | 0.159 | Creatine kinase inhibitor | 0.102 0.057 DBMET00415 | ||
| 0.14 | 0.004 | 0.14 | Glutamate (mGluR1a) antagonist | 0.061 0.014 DBMET00415 | ||
| 0.14 | 0.004 | 0.14 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.118 0.006 DBMET00415 | ||
| 0.152 | 0.016 | 0.152 | CYP2A6 inhibitor | |||
| 0.229 | 0.093 | 0.229 | DNA damaging | |||
| 0.164 | 0.032 | 0.164 | Granulocyte macrophage colony stimulating factor antagonist | 0.114 0.058 DBMET00415 | ||
| 0.149 | 0.017 | 0.149 | Acetylcholine release stimulant | |||
| 0.208 | 0.076 | 0.208 | Psychostimulant | |||
| 0.172 | 0.041 | 0.172 | MAP kinase 3 inhibitor | 0.158 0.056 DBMET00415 | ||
| 0.256 | 0.128 | 0.256 | Vasodilator, coronary | |||
| 0.13 | 0.004 | 0.13 | Glutamate (mGluR group II) antagonist | 0.043 0.021 DBMET00415 | ||
| 0.141 | 0.015 | 0.141 | Tyk2 inhibitor | 0.073 0.04 DBMET00415 | ||
| 0.251 | 0.125 | 0.251 | Antithrombotic | |||
| 0.197 | 0.072 | 0.197 | Focal adhesion kinase 2 inhibitor | 0.171 0.099 DBMET00415 | ||
| 0.198 | 0.076 | 0.198 | Death-associated protein kinase 3 inhibitor | 0.146 0.129 DBMET00415 | ||
| 0.129 | 0.007 | 0.129 | I kappa B kinase 2 inhibitor | 0.084 0.02 DBMET00415 | ||
| 0.248 | 0.127 | 0.248 | Cholesterol antagonist | |||
| 0.205 | 0.084 | 0.205 | EphB2 antagonist | |||
| 0.151 | 0.031 | 0.151 | Protein kinase C gamma inhibitor | 0.125 0.048 DBMET00415 | ||
| 0.125 | 0.006 | 0.125 | Histone deacetylase SIRT3 inhibitor | 0.086 0.014 DBMET00415 | ||
| 0.138 | 0.02 | 0.145 | Rho-associated kinase II inhibitor | 0.145 0.018 DBMET00415 | DBMET00415 | |
| 0.152 | 0.034 | 0.152 | MAP kinase kinase kinase inhibitor | 0.094 0.072 DBMET00415 | ||
| 0.19 | 0.072 | 0.267 | Tyrosine kinase inhibitor | 0.267 0.05 DBMET00415 | DBMET00415 | |
| 0.126 | 0.009 | 0.126 | Secretase beta inhibitor | 0.121 0.01 DBMET00415 | ||
| 0.151 | 0.035 | 0.151 | GABA receptor agonist | 0.119 0.057 DBMET00415 | ||
| 0.125 | 0.01 | 0.125 | Glutamate (mGluR1) antagonist | |||
| 0.221 | 0.106 | 0.221 | 5 Hydroxytryptamine release stimulant | 0.179 0.142 DBMET00415 | ||
| 0.125 | 0.011 | 0.125 | Transforming growth factor antagonist | |||
| 0.208 | 0.094 | 0.208 | Antiamyloidogenic | |||
| 0.172 | 0.059 | 0.172 | Neurotensin receptor agonist | 0.15 0.101 DBMET00415 | ||
| 0.118 | 0.005 | 0.118 | Exportin-1 inhibitor | 0.064 0.06 DBMET00415 | ||
| 0.133 | 0.02 | 0.151 | MAP-kinase-activated kinase inhibitor | 0.151 0.014 DBMET00415 | DBMET00415 | |
| 0.115 | 0.004 | 0.115 | Glutamate (mGluR2) antagonist | 0.032 0.018 DBMET00415 | ||
| 0.141 | 0.03 | 0.141 | CDK2/cyclin A inhibitor | 0.134 0.033 DBMET00415 | ||
| 0.144 | 0.033 | 0.144 | Carbonic anhydrase XV inhibitor | |||
| 0.125 | 0.015 | 0.134 | Janus tyrosine kinase 1 inhibitor | 0.134 0.012 DBMET00415 | DBMET00415 | |
| 0.204 | 0.094 | 0.204 | Peptidyltransferase inhibitor | 0.172 0.142 DBMET00415 | ||
| 0.168 | 0.06 | 0.168 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.171 | 0.064 | 0.171 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.217 | 0.112 | 0.217 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.141 | 0.037 | 0.141 | CC chemokine 6 receptor antagonist | 0.132 0.064 DBMET00415 | ||
| 0.144 | 0.04 | 0.144 | Cyclin-dependent kinase 2 inhibitor | 0.114 0.057 DBMET00415 | ||
| 0.116 | 0.013 | 0.116 | Human rhinovirus A protease inhibitor | 0.062 0.033 DBMET00415 | ||
| 0.118 | 0.016 | 0.118 | Carbamoyl phosphate synthetase inhibitor | 0.095 0.022 DBMET00415 | ||
| 0.175 | 0.074 | 0.175 | MAP kinase kinase 5 inhibitor | 0.163 0.105 DBMET00415 | ||
| 0.173 | 0.072 | 0.173 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.141 | 0.04 | 0.141 | DNA repair enzyme inhibitor | 0.122 0.069 DBMET00415 | ||
| 0.141 | 0.041 | 0.141 | 5 Hydroxytryptamine 3A agonist | 0.132 0.047 DBMET00415 | ||
| 0.187 | 0.089 | 0.187 | Histone acetyltransferase inhibitor | |||
| 0.13 | 0.032 | 0.13 | Folate antagonist | |||
| 0.128 | 0.031 | 0.128 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.092 0.054 DBMET00415 | ||
| 0.113 | 0.016 | 0.113 | MAP3K7 inhibitor | 0.085 0.034 DBMET00415 | ||
| 0.102 | 0.006 | 0.102 | Corticotropin releasing factor 2 receptor antagonist | 0.078 0.019 DBMET00415 | ||
| 0.107 | 0.011 | 0.107 | Protein kinase C beta inhibitor | 0.078 0.033 DBMET00415 | ||
| 0.098 | 0.004 | 0.098 | Dopamine beta hydroxylase inhibitor | 0.066 0.01 DBMET00415 | ||
| 0.1 | 0.008 | 0.1 | Aconitate hydratase inhibitor | 0.065 0.022 DBMET00415 | ||
| 0.13 | 0.038 | 0.13 | MAP kinase 8 inhibitor | |||
| 0.11 | 0.019 | 0.121 | CDC7 inhibitor | 0.121 0.015 DBMET00415 | DBMET00415 | |
| 0.096 | 0.004 | 0.096 | Protein kinase (CK1) epsilon inhibitor | 0.052 0.011 DBMET00415 | ||
| 0.113 | 0.022 | 0.113 | Glutamate (mGluR group I) antagonist | |||
| 0.129 | 0.038 | 0.129 | Carbonic anhydrase III inhibitor | |||
| 0.117 | 0.026 | 0.117 | Phosphofructokinase-1 inhibitor | 0.079 0.042 DBMET00415 | ||
| 0.132 | 0.042 | 0.132 | Transcription factor STAT6 inhibitor | 0.105 0.094 DBMET00415 | ||
| 0.138 | 0.049 | 0.138 | Protein kinase (CK2) alpha inhibitor | |||
| 0.098 | 0.01 | 0.098 | Glutamate (mGluR group III) agonist | |||
| 0.093 | 0.005 | 0.093 | Histamine H2 receptor agonist | 0.088 0.005 DBMET00415 | ||
| 0.152 | 0.064 | 0.152 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.12 0.084 DBMET00415 | ||
| 0.152 | 0.065 | 0.152 | Activin receptor-like kinase 2 inhibitor | 0.131 0.083 DBMET00415 | ||
| 0.105 | 0.019 | 0.105 | Transforming growth factor beta 3 antagonist | |||
| 0.109 | 0.024 | 0.132 | MAP-kinase-activated kinase 2 inhibitor | 0.132 0.016 DBMET00415 | DBMET00415 | |
| 0.097 | 0.012 | 0.097 | Glutamate (mGluR6) antagonist | 0.072 0.036 DBMET00415 | ||
| 0.098 | 0.013 | 0.098 | Protein kinase C epsilon inhibitor | 0.059 0.032 DBMET00415 | ||
| 0.116 | 0.032 | 0.116 | Histamine N-methyltransferase inhibitor | 0.106 0.04 DBMET00415 | ||
| 0.151 | 0.067 | 0.199 | Hemostatic | 0.199 0.033 DBMET00415 | DBMET00415 | |
| 0.092 | 0.009 | 0.092 | Stearoyl-CoA desaturase inhibitor | 0.044 0.03 DBMET00415 | ||
| 0.093 | 0.009 | 0.093 | Glutamate (mGluR group I) agonist | 0.042 0.04 DBMET00415 | ||
| 0.107 | 0.024 | 0.107 | Aminopeptidase I inhibitor | 0.08 0.042 DBMET00415 | ||
| 0.143 | 0.062 | 0.143 | Ca2+-transporting ATPase inhibitor | 0.132 0.108 DBMET00415 | ||
| 0.213 | 0.132 | 0.214 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.214 0.13 DBMET00415 | DBMET00415 | |
| 0.113 | 0.033 | 0.113 | NADH dehydrogenase inhibitor | 0.102 0.042 DBMET00415 | ||
| 0.09 | 0.01 | 0.096 | Diacylglycerol O-acyltransferase inhibitor | 0.096 0.008 DBMET00415 | DBMET00415 | |
| 0.186 | 0.107 | 0.186 | Dyrk kinase inhibitor | |||
| 0.135 | 0.056 | 0.135 | Alkylator | |||
| 0.095 | 0.016 | 0.095 | Pim-2 kinase inhibitor | 0.069 0.024 DBMET00415 | ||
| 0.108 | 0.031 | 0.108 | Inducible nitric-oxide synthase inhibitor | |||
| 0.12 | 0.043 | 0.12 | UDP-glucose 4-epimerase inhibitor | 0.114 0.048 DBMET00415 | ||
| 0.105 | 0.028 | 0.105 | Granulocyte macrophage colony stimulating factor agonist | 0.089 0.053 DBMET00415 | ||
| 0.113 | 0.037 | 0.113 | Triose-phosphate isomerase inhibitor | 0.091 0.058 DBMET00415 | ||
| 0.252 | 0.175 | 0.252 | Antibacterial | 0.231 0.195 DBMET00415 | ||
| 0.206 | 0.13 | 0.206 | Transcription factor STAT inhibitor | |||
| 0.136 | 0.06 | 0.136 | Antibacterial (Helicobacter pylori) | |||
| 0.099 | 0.023 | 0.099 | Nav1.7 sodium channel blocker | 0.074 0.039 DBMET00415 | ||
| 0.106 | 0.032 | 0.112 | Rho-associated kinase inhibitor | 0.112 0.029 DBMET00415 | DBMET00415 | |
| 0.092 | 0.018 | 0.092 | Aryl hydrocarbon receptor antagonist | |||
| 0.161 | 0.087 | 0.161 | Phospholipase C inhibitor | |||
| 0.088 | 0.015 | 0.088 | AMPA receptor antagonist | 0.044 0.038 DBMET00415 | ||
| 0.091 | 0.018 | 0.091 | Ornithine carbamoyltransferase inhibitor | 0.048 0.041 DBMET00415 | ||
| 0.093 | 0.02 | 0.093 | MAP kinase kinase 7 inhibitor | 0.09 0.025 DBMET00415 | ||
| 0.102 | 0.029 | 0.102 | Glutamate decarboxylase inhibitor | |||
| 0.081 | 0.009 | 0.081 | Adenosine deaminase inhibitor | 0.07 0.013 DBMET00415 | ||
| 0.089 | 0.018 | 0.089 | Bruton tyrosine kinase inhibitor | 0.054 0.042 DBMET00415 | ||
| 0.139 | 0.068 | 0.139 | Cyclin-dependent kinase 7 inhibitor | |||
| 0.134 | 0.063 | 0.134 | Cyclooxygenase 3 inhibitor | |||
| 0.087 | 0.017 | 0.087 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.073 0.024 DBMET00415 | ||
| 0.122 | 0.052 | 0.122 | Nav1.5 sodium channel blocker | |||
| 0.097 | 0.027 | 0.097 | Phenylalanine 4-hydroxylase inhibitor | 0.081 0.037 DBMET00415 | ||
| 0.104 | 0.034 | 0.104 | GABA A receptor agonist | 0.086 0.053 DBMET00415 | ||
| 0.14 | 0.07 | 0.14 | Cytokine production inhibitor | |||
| 0.088 | 0.019 | 0.088 | Glutamate (mGluR7) antagonist | 0.065 0.053 DBMET00415 | ||
| 0.085 | 0.016 | 0.085 | Fatty acid synthase inhibitor | |||
| 0.194 | 0.126 | 0.194 | Interleukin agonist | 0.187 0.133 DBMET00415 | ||
| 0.072 | 0.004 | 0.072 | Histamine H1 receptor agonist | 0.061 0.008 DBMET00415 | ||
| 0.112 | 0.044 | 0.112 | Nitric-oxide synthase inhibitor | |||
| 0.12 | 0.052 | 0.12 | Aminopeptidase B inhibitor | 0.084 0.078 DBMET00415 | ||
| 0.09 | 0.022 | 0.09 | Protein kinase C iota inhibitor | |||
| 0.11 | 0.042 | 0.11 | Glutamate (mGluR7) agonist | |||
| 0.089 | 0.022 | 0.089 | Carbonic anhydrase stimulant | 0.059 0.041 DBMET00415 | ||
| 0.085 | 0.02 | 0.085 | Acyl-CoA dehydrogenase inhibitor | 0.06 0.033 DBMET00415 | ||
| 0.099 | 0.035 | 0.099 | mTOR complex 2 inhibitor | |||
| 0.097 | 0.033 | 0.097 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.098 | 0.034 | 0.098 | Phosphodiesterase XI inhibitor | |||
| 0.098 | 0.034 | 0.098 | Phosphodiesterase 11A inhibitor | |||
| 0.092 | 0.029 | 0.092 | Phosphodiesterase 4B inhibitor | |||
| 0.078 | 0.015 | 0.078 | Transforming growth factor beta 1 antagonist | |||
| 0.141 | 0.078 | 0.148 | Adenylate cyclase stimulant | 0.148 0.067 DBMET00415 | DBMET00415 | |
| 0.217 | 0.154 | 0.217 | Transcription factor NF kappa B inhibitor | |||
| 0.093 | 0.03 | 0.093 | Protein kinase B beta inhibitor | 0.069 0.059 DBMET00415 | ||
| 0.127 | 0.065 | 0.127 | TRKB antagonist | |||
| 0.118 | 0.055 | 0.118 | Activin receptor-like kinase 4 inhibitor | |||
| 0.102 | 0.04 | 0.102 | Bcr-Abl kinase inhibitor | |||
| 0.144 | 0.082 | 0.144 | Diuretic | |||
| 0.124 | 0.062 | 0.124 | Proteasome inhibitor | |||
| 0.088 | 0.028 | 0.088 | MAP kinase kinase 8 inhibitor | |||
| 0.091 | 0.031 | 0.091 | Benzodiazepine agonist | |||
| 0.138 | 0.079 | 0.138 | CDC-like kinase 1 inhibitor | |||
| 0.083 | 0.024 | 0.092 | Argininosuccinate synthase inhibitor | 0.092 0.021 DBMET00415 | DBMET00415 | |
| 0.066 | 0.007 | 0.066 | Nerve growth factor antagonist | |||
| 0.135 | 0.077 | 0.148 | Ribosomal protein S6 kinase inhibitor | 0.148 0.066 DBMET00415 | DBMET00415 | |
| 0.106 | 0.048 | 0.106 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.098 0.056 DBMET00415 | ||
| 0.154 | 0.096 | 0.154 | Tumour necrosis factor antagonist | |||
| 0.136 | 0.079 | 0.136 | Vascular endothelial growth factor 3 antagonist | |||
| 0.111 | 0.054 | 0.111 | Protein kinase (CK2) inhibitor | |||
| 0.168 | 0.111 | 0.168 | Angiogenesis stimulant | |||
| 0.096 | 0.04 | 0.096 | Hematopoietic | |||
| 0.118 | 0.063 | 0.118 | Glycogen synthase kinase-3 beta inhibitor | |||
| 0.11 | 0.055 | 0.11 | Urease inhibitor | |||
| 0.073 | 0.018 | 0.073 | Histamine agonist | 0.065 0.023 DBMET00415 | ||
| 0.093 | 0.039 | 0.093 | D-Ala-D-Ala ligase inhibitor | 0.081 0.066 DBMET00415 | ||
| 0.068 | 0.014 | 0.068 | Glutamate (mGluR5) agonist | |||
| 0.061 | 0.008 | 0.061 | Glutamate (mGluR4) agonist | 0.031 0.029 DBMET00415 | ||
| 0.058 | 0.005 | 0.058 | Transforming growth factor beta 2 antagonist | |||
| 0.071 | 0.018 | 0.071 | Epithelial sodium channel blocker | |||
| 0.082 | 0.029 | 0.082 | Potassium channel (Tandem pore domain) blocker | |||
| 0.065 | 0.012 | 0.068 | AICAR transformylase inhibitor | 0.068 0.01 DBMET00415 | DBMET00415 | |
| 0.082 | 0.029 | 0.082 | 5 Hydroxytryptamine 3A antagonist | 0.059 0.057 DBMET00415 | ||
| 0.137 | 0.085 | 0.137 | Heat shock protein 70 antagonist | |||
| 0.139 | 0.087 | 0.139 | MAP kinase kinase 4 inhibitor | |||
| 0.11 | 0.058 | 0.11 | Mediator release inhibitor | |||
| 0.062 | 0.011 | 0.062 | Kainate receptor 2 antagonist | 0.033 0.027 DBMET00415 | ||
| 0.093 | 0.043 | 0.093 | Histamine H2 receptor antagonist | 0.083 0.06 DBMET00415 | ||
| 0.062 | 0.012 | 0.062 | Geranyltranstransferase inhibitor | |||
| 0.072 | 0.023 | 0.072 | Bombesin 3 receptor antagonist | |||
| 0.083 | 0.035 | 0.083 | GABA B receptor agonist | |||
| 0.108 | 0.061 | 0.108 | AMP-activated protein kinase stimulant | 0.096 0.076 DBMET00415 | ||
| 0.065 | 0.018 | 0.065 | Farnesyltransferase inhibitor | |||
| 0.169 | 0.123 | 0.169 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.084 | 0.038 | 0.084 | Syk tyrosine kinase inhibitor | 0.076 0.043 DBMET00415 | ||
| 0.087 | 0.041 | 0.087 | Keratolytic | |||
| 0.067 | 0.021 | 0.067 | Chemokine receptor agonist | |||
| 0.111 | 0.066 | 0.111 | Cystathionine beta-synthase inhibitor | |||
| 0.13 | 0.086 | 0.13 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.066 | 0.023 | 0.072 | Antimetabolite | 0.072 0.021 DBMET00415 | DBMET00415 | |
| 0.153 | 0.111 | 0.153 | Anesthetic general | |||
| 0.062 | 0.019 | 0.062 | HCV NS3/NS4A protease inhibitor | |||
| 0.109 | 0.066 | 0.109 | Mucolytic | |||
| 0.111 | 0.069 | 0.111 | Glycogen synthase kinase-3 inhibitor | |||
| 0.162 | 0.122 | 0.162 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.056 | 0.015 | 0.056 | Glutamate (mGluR group III) antagonist | |||
| 0.054 | 0.014 | 0.054 | Alpha 1d adrenoreceptor agonist | |||
| 0.067 | 0.027 | 0.067 | Cyclin A1 inhibitor | 0.067 0.026 DBMET00415 | ||
| 0.053 | 0.014 | 0.053 | Factor XIIIa inhibitor | |||
| 0.122 | 0.083 | 0.122 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.186 | 0.147 | 0.186 | Neuropeptide Y2 antagonist | |||
| 0.043 | 0.005 | 0.043 | Purinergic P2Y15 antagonist | 0.035 0.01 DBMET00415 | ||
| 0.078 | 0.041 | 0.078 | Protein kinase B alpha inhibitor | 0.061 0.06 DBMET00415 | ||
| 0.117 | 0.081 | 0.168 | RET inhibitor | 0.168 0.053 DBMET00415 | DBMET00415 | |
| 0.125 | 0.089 | 0.125 | Nav1.6 sodium channel blocker | |||
| 0.072 | 0.037 | 0.072 | Cyclin A2 inhibitor | |||
| 0.094 | 0.06 | 0.094 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.045 | 0.011 | 0.045 | AMPA 3 receptor antagonist | |||
| 0.075 | 0.041 | 0.075 | Carbonic anhydrase VA inhibitor | |||
| 0.13 | 0.097 | 0.13 | Thiol protease inhibitor | |||
| 0.096 | 0.063 | 0.096 | Electrolyte absorption antagonist | |||
| 0.175 | 0.142 | 0.175 | Calpain inhibitor | |||
| 0.038 | 0.005 | 0.038 | Glucosylceramidase stimulant | |||
| 0.07 | 0.037 | 0.07 | Cyclin A inhibitor | |||
| 0.074 | 0.042 | 0.074 | Neuronal nicotinic receptor antagonist | 0.066 0.048 DBMET00415 | ||
| 0.136 | 0.105 | 0.136 | Arachidonic acid antagonist | |||
| 0.069 | 0.038 | 0.069 | Protease 3C (Human rhinovirus) inhibitor | 0.058 0.057 DBMET00415 | ||
| 0.047 | 0.017 | 0.047 | Diamine oxidase inhibitor | 0.033 0.032 DBMET00415 | ||
| 0.044 | 0.013 | 0.044 | ATM kinase inhibitor | |||
| 0.079 | 0.048 | 0.141 | Janus tyrosine kinase 2 inhibitor | 0.141 0.023 DBMET00415 | DBMET00415 | |
| 0.05 | 0.021 | 0.05 | Glutamate (mGluR4) antagonist | |||
| 0.041 | 0.012 | 0.041 | ATR kinase inhibitor | 0.036 0.016 DBMET00415 | ||
| 0.045 | 0.016 | 0.045 | Glutamate (mGluR8) agonist | |||
| 0.037 | 0.008 | 0.037 | MAP3K8 inhibitor | |||
| 0.065 | 0.036 | 0.065 | Neuropeptide agonist | |||
| 0.046 | 0.018 | 0.046 | Vascular adhesion protein 1 inhibitor | |||
| 0.038 | 0.009 | 0.038 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.074 | 0.046 | 0.074 | Glycine receptor agonist | |||
| 0.044 | 0.016 | 0.044 | Glutamate (mGluR3) antagonist | |||
| 0.032 | 0.004 | 0.032 | Complement factor D inhibitor | 0.02 0.009 DBMET00415 | ||
| 0.159 | 0.131 | 0.159 | Aldehyde oxidase inhibitor | |||
| 0.07 | 0.043 | 0.07 | Acetylcholine M5 receptor agonist | |||
| 0.038 | 0.011 | 0.038 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.081 | 0.055 | 0.081 | Acetylcholine nicotinic agonist | |||
| 0.071 | 0.044 | 0.071 | Sirtuin 1 inhibitor | 0.069 0.045 DBMET00415 | ||
| 0.041 | 0.014 | 0.041 | Tryptophan 5 hydroxylase inhibitor | 0.035 0.026 DBMET00415 | ||
| 0.034 | 0.008 | 0.034 | Glutamate (mGluR1) agonist | 0.024 0.019 DBMET00415 | ||
| 0.034 | 0.007 | 0.034 | Glutamate (mGluR1a) agonist | |||
| 0.054 | 0.028 | 0.054 | Bombesin 2 receptor antagonist | |||
| 0.063 | 0.037 | 0.063 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.13 | 0.104 | 0.13 | Hexokinase inhibitor | |||
| 0.101 | 0.075 | 0.101 | Nav1.4 sodium channel blocker | |||
| 0.108 | 0.083 | 0.108 | Cyclin-dependent kinase inhibitor | |||
| 0.038 | 0.013 | 0.091 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.091 0.005 DBMET00415 | DBMET00415 | |
| 0.031 | 0.006 | 0.031 | ICAM 1 antagonist | |||
| 0.081 | 0.056 | 0.081 | Histamine H1 receptor antagonist | |||
| 0.061 | 0.038 | 0.061 | Heat shock protein 90 beta antagonist | |||
| 0.044 | 0.021 | 0.044 | Membrane dipeptidase inhibitor | 0.039 0.027 DBMET00415 | ||
| 0.071 | 0.048 | 0.071 | Amidase inhibitor | |||
| 0.065 | 0.042 | 0.065 | 5 Hydroxytryptamine 3 agonist | |||
| 0.05 | 0.027 | 0.05 | CC chemokine 4 receptor antagonist | |||
| 0.056 | 0.034 | 0.056 | Lysine-specific demethylase 1A inhibitor | |||
| 0.044 | 0.022 | 0.044 | Kainate receptor agonist | 0.042 0.027 DBMET00415 | ||
| 0.032 | 0.01 | 0.032 | Hedgehog signaling activator | |||
| 0.128 | 0.106 | 0.128 | Pregnane X receptor agonist | |||
| 0.116 | 0.094 | 0.116 | Interleukin 1 antagonist | |||
| 0.035 | 0.013 | 0.035 | CDK4/cyclin D3 inhibitor | |||
| 0.047 | 0.025 | 0.047 | Dipeptidyl peptidase IV inhibitor | |||
| 0.055 | 0.033 | 0.055 | Dipeptidyl peptidase inhibitor | |||
| 0.042 | 0.02 | 0.042 | DNA gyrase subunit B inhibitor | 0.034 0.033 DBMET00415 | ||
| 0.083 | 0.062 | 0.096 | 3C-Like protease (SARS coronavirus) inhibitor | 0.096 0.037 DBMET00415 | DBMET00415 | |
| 0.057 | 0.036 | 0.057 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.067 | 0.046 | 0.067 | Potassium channel (ATP-sensitive) blocker | |||
| 0.036 | 0.016 | 0.036 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.037 | 0.017 | 0.037 | HCV polyprotein inhibitor | |||
| 0.066 | 0.046 | 0.066 | Carbonic anhydrase V inhibitor | |||
| 0.048 | 0.029 | 0.048 | Benzodiazepine inverse agonist | |||
| 0.057 | 0.038 | 0.057 | Ribonucleotide reductase inhibitor | |||
| 0.081 | 0.061 | 0.081 | Phosphodiesterase IV inhibitor | |||
| 0.038 | 0.019 | 0.038 | CXC chemokine receptor agonist | |||
| 0.042 | 0.023 | 0.042 | MAP3K5 inhibitor | |||
| 0.036 | 0.017 | 0.036 | AMPA 1 receptor antagonist | |||
| 0.127 | 0.108 | 0.127 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.049 | 0.031 | 0.049 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.085 | 0.067 | 0.085 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.06 | 0.043 | 0.06 | Purinergic P2X1 antagonist | |||
| 0.043 | 0.026 | 0.043 | Kainate receptor antagonist | |||
| 0.035 | 0.019 | 0.035 | Protein kinase (CK2) beta inhibitor | 0.031 0.03 DBMET00415 | ||
| 0.049 | 0.033 | 0.049 | Cytokine production stimulant | |||
| 0.021 | 0.005 | 0.021 | CDK2/cyclin A3 inhibitor | 0.017 0.01 DBMET00415 | ||
| 0.087 | 0.071 | 0.087 | Protein kinase C zeta inhibitor | |||
| 0.058 | 0.043 | 0.058 | Bombesin 1 receptor agonist | 0.055 0.047 DBMET00415 | ||
| 0.031 | 0.017 | 0.085 | Histamine H3 receptor agonist | 0.085 0.007 DBMET00415 | DBMET00415 | |
| 0.058 | 0.043 | 0.058 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.037 | 0.022 | 0.037 | Calcitonin receptor agonist | |||
| 0.033 | 0.019 | 0.033 | Acetylcholine M4 receptor agonist | |||
| 0.036 | 0.022 | 0.036 | Fumarate hydratase inhibitor | |||
| 0.081 | 0.067 | 0.081 | Ornithine decarboxylase inhibitor | |||
| 0.027 | 0.013 | 0.027 | Complement factor 1s inhibitor | |||
| 0.059 | 0.044 | 0.059 | Alpha 2 adrenoreceptor agonist | |||
| 0.055 | 0.042 | 0.055 | Xanthine dehydrogenase inhibitor | |||
| 0.023 | 0.009 | 0.023 | Toll-Like receptor 8 agonist | |||
| 0.058 | 0.045 | 0.058 | Cyclin D1 inhibitor | |||
| 0.104 | 0.091 | 0.104 | Aldehyde dehydrogenase inhibitor | 0.1 0.098 DBMET00415 | ||
| 0.075 | 0.063 | 0.075 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.023 | 0.01 | 0.023 | Factor XIII inhibitor | |||
| 0.044 | 0.032 | 0.118 | Poly(ADP-ribose) polymerase inhibitor | 0.118 0.006 DBMET00415 | DBMET00415 | |
| 0.062 | 0.05 | 0.062 | Histone deacetylase inhibitor | |||
| 0.068 | 0.057 | 0.068 | Phospholipase D inhibitor | |||
| 0.041 | 0.03 | 0.041 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.039 | 0.029 | 0.039 | VCAM-1 antagonist | |||
| 0.044 | 0.034 | 0.044 | Factor Xa inhibitor | |||
| 0.054 | 0.044 | 0.054 | Immunoglobulin Fc receptor antagonist | |||
| 0.039 | 0.029 | 0.039 | VCAM antagonist | |||
| 0.03 | 0.02 | 0.03 | AMPA 2 receptor antagonist | |||
| 0.022 | 0.012 | 0.022 | Hexokinase stimulant | |||
| 0.145 | 0.135 | 0.145 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.073 | 0.064 | 0.073 | Acetylcholine nicotinic antagonist | |||
| 0.183 | 0.174 | 0.228 | Gastrin inhibitor | 0.228 0.108 DBMET00415 | DBMET00415 | |
| 0.02 | 0.011 | 0.02 | Cyclin T1 inhibitor | |||
| 0.052 | 0.043 | 0.052 | Thromboxane synthase inhibitor | |||
| 0.018 | 0.009 | 0.018 | Nicotinic alpha4 receptor agonist | |||
| 0.05 | 0.041 | 0.05 | Toll-Like receptor 8 antagonist | |||
| 0.031 | 0.022 | 0.031 | Potassium channel small-conductance Ca-activated activator | |||
| 0.183 | 0.175 | 0.187 | Hypoxia-inducible factor 1 alpha inhibitor | 0.187 0.168 DBMET00415 | DBMET00415 | |
| 0.068 | 0.06 | 0.068 | Rho-associated kinase I inhibitor | |||
| 0.052 | 0.045 | 0.052 | MAP kinase kinase 9 inhibitor | |||
| 0.018 | 0.01 | 0.018 | CC chemokine 9 receptor antagonist | |||
| 0.032 | 0.025 | 0.032 | Plasma kallikrein inhibitor | |||
| 0.026 | 0.019 | 0.026 | Thymidine phosphorylase inhibitor | |||
| 0.046 | 0.039 | 0.046 | Potassium channel (Inward rectifier) blocker | |||
| 0.043 | 0.037 | 0.043 | Thymidylate synthase inhibitor | |||
| 0.01 | 0.003 | 0.01 | CC chemokine 6 receptor agonist | 0.006 0.005 DBMET00415 | ||
| 0.077 | 0.07 | 0.077 | Acetylcholine agonist | |||
| 0.088 | 0.081 | 0.088 | Gastric antisecretory | |||
| 0.027 | 0.02 | 0.027 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.035 | 0.029 | 0.035 | Melanocortin 1 antagonist | |||
| 0.027 | 0.021 | 0.027 | Thrombin receptor antagonist | |||
| 0.176 | 0.17 | 0.176 | Transcription factor STAT3 inhibitor | |||
| 0.085 | 0.08 | 0.085 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.104 | 0.099 | 0.104 | Cathepsin H inhibitor | |||
| 0.026 | 0.021 | 0.028 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.028 0.019 DBMET00415 | DBMET00415 | |
| 0.034 | 0.029 | 0.034 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.045 | 0.04 | 0.045 | Adenosine A2b receptor antagonist | |||
| 0.07 | 0.065 | 0.071 | Fibroblast growth factor 3 antagonist | 0.071 0.064 DBMET00415 | DBMET00415 | |
| 0.078 | 0.074 | 0.281 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.281 0.01 DBMET00415 | DBMET00415 | |
| 0.02 | 0.016 | 0.02 | Geranylgeranyltransferase I inhibitor | |||
| 0.088 | 0.084 | 0.088 | Falcipain 3 inhibitor | |||
| 0.095 | 0.09 | 0.095 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | |||
| 0.069 | 0.065 | 0.069 | Phosphodiesterase VI inhibitor | |||
| 0.021 | 0.017 | 0.021 | Geranylgeranyltransferase inhibitor | |||
| 0.094 | 0.09 | 0.094 | Abl kinase inhibitor | |||
| 0.029 | 0.025 | 0.029 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.145 | 0.141 | 0.145 | Potassium channel blocker | |||
| 0.026 | 0.022 | 0.026 | Protocollagen prolyl hydroxylase inhibitor | |||
| 0.049 | 0.046 | 0.049 | Carbonic anhydrase VB inhibitor | |||
| 0.058 | 0.055 | 0.058 | Phosphodiesterase 1C inhibitor | |||
| 0.055 | 0.052 | 0.055 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.013 | 0.01 | 0.013 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.014 | 0.012 | 0.014 | Egl nine homolog 1 inhibitor | |||
| 0.017 | 0.015 | 0.017 | Histamine H4 receptor agonist | |||
| 0.104 | 0.102 | 0.104 | Phosphodiesterase inhibitor | |||
| 0.201 | 0.2 | 0.539 | Toll-Like receptor agonist | 0.539 0.025 DBMET00415 | DBMET00415 | |
| 0.025 | 0.024 | 0.025 | Myristoyl transferase inhibitor | |||
| 0.1 | 0.098 | 0.1 | Nav1.3 sodium channel blocker | |||
| 0.048 | 0.047 | 0.048 | Alpha-mannosidase inhibitor | |||
| 0.093 | 0.092 | 0.093 | Aurora-B kinase inhibitor | |||
| 0.048 | 0.047 | 0.048 | Nicotinic neuronal receptor agonist | |||
| 0.014 | 0.013 | 0.014 | Dipeptidyl peptidase IX inhibitor | |||
| 0.071 | 0.07 | 0.071 | Protein kinase A inhibitor | |||
| 0.024 | 0.023 | 0.024 | Lysine carboxypeptidase inhibitor | |||
| 0.081 | 0.08 | 0.081 | Prolactin inhibitor | |||
| 0.033 | 0.034 | 0.083 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.083 0.009 DBMET00415 | DBMET00415 | |
| 0.01 | 0.011 | 0.011 | Purine nucleoside phosphorylase inhibitor | 0.011 0.009 DBMET00415 | DBMET00415 | |
| 0.077 | 0.099 | 0.088 | Insulin receptor antagonist | 0.088 0.08 DBMET00415 | DBMET00415 | |
| 0.19 | 0.214 | 0.532 | Toll-Like receptor 7 agonist | 0.532 0.026 DBMET00415 | DBMET00415 | |
| 0.025 | 0.05 | 0.047 | Carbonic anhydrase I stimulant | 0.047 0.018 DBMET00415 | DBMET00415 | |
| 0.149 | 0.177 | 0.208 | Cardiotonic | 0.208 0.111 DBMET00415 | DBMET00415 | |
| 0.04 | 0.073 | 0.053 | Carbonic anhydrase II stimulant | 0.053 0.034 DBMET00415 | DBMET00415 | |
| 0.049 | 0.083 | 0.248 | Raf kinase inhibitor | 0.248 0.009 DBMET00415 | DBMET00415 | |
| 0.108 | 0.174 | 0.411 | Interleukin antagonist | 0.411 0.029 DBMET00415 | DBMET00415 | |
| 0.157 | 0.231 | 0.24 | Vasodilator, peripheral | 0.24 0.135 DBMET00415 | DBMET00415 | |
| 0.048 | 0.125 | 0.077 | ALK inhibitor | 0.077 0.063 DBMET00415 | DBMET00415 | |
| 0.021 | 0.108 | 0.037 | Somatostatin 4 agonist | 0.037 0.026 DBMET00415 | DBMET00415 | |
| 0.063 | 0.162 | 0.343 | MAP kinase 12 inhibitor | 0.343 0.005 DBMET00415 | DBMET00415 | |
| 0.036 | 0.137 | 0.069 | CXC chemokine receptor antagonist | 0.069 0.051 DBMET00415 | DBMET00415 | |
| 0.023 | 0.126 | 0.208 | Raf kinase B inhibitor | 0.208 0.009 DBMET00415 | DBMET00415 | |
| 0.186 | 0.298 | 0.292 | Calcium channel L-type activator | 0.292 0.164 DBMET00415 | DBMET00415 | |
| 0.041 | 0.162 | 0.121 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.121 0.067 DBMET00415 | DBMET00415 | |
| 0.035 | 0.16 | 0.233 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.233 0.004 DBMET00415 | DBMET00415 | |
| 0.061 | 0.212 | 0.15 | Src kinase inhibitor | 0.15 0.083 DBMET00415 | DBMET00415 | |
| 0.058 | 0.222 | 0.158 | Alpha 2d adrenoreceptor antagonist | 0.158 0.007 DBMET00415 | DBMET00415 | |
| 0.15 | 0.359 | 0.315 | Cyclophilin D inhibitor | 0.315 0.149 DBMET00415 | DBMET00415 | |
| 0.006 | 0.284 | 0.03 | Alpha 2d adrenoreceptor agonist | 0.03 0.009 DBMET00415 | DBMET00415 | |
| 0.021 | 0.316 | 0.123 | c-Src kinase inhibitor | 0.123 0.073 DBMET00415 | DBMET00415 | |
| 0.039 | 0.471 | 0.162 | Vasodilator | 0.162 0.14 DBMET00415 | DBMET00415 | |
| 0.025 | 0.58 | 0.659 | Interleukin 5 antagonist | 0.659 0.002 DBMET00415 | DBMET00415 | |
| 0.002 | 0.835 | 0.02 | Thyroid hormone alpha agonist | 0.02 0.007 DBMET00415 | DBMET00415 | |
| 0.002 | 0.92 | 0.02 | Thyroid hormone alpha antagonist | 0.02 0.008 DBMET00415 | DBMET00415 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |